yingweiwo

PCSK9

PCSK9

PCSK9 related products

Structure Cat No. Product Name CAS No. Product Description
(R,R)-PCSK9 degrader 1 V87650 (R,R)-PCSK9 degrader 1 2216703-12-5 (R,R)-PCSK9 degrader 1 is an isomer of PCSK9 degrader 1.
7030B-C5 V98991 7030B-C5 370871-42-4 7030B-C5 is a PCSK9 inhibitor (IC50=1.61 μM).
ALD306 V128487 ALD306 ALD306 is a human monoclonal antibody (mAb) that targets PCSK9.
AZD8233 V87653 AZD8233 2604215-74-7 AZD8233 is a liver-targeting antisense oligonucleotide that inhibits proprotein convertase/subtilisin 9 (PCSK9) protein synthesis.
AZD8233 sodium V87655 AZD8233 sodium AZD8233 sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis.
AZD8233 sodium scrambled negative control V129726 AZD8233 sodium scrambled negative control The AZD8233 sodium scrambled negative control is a negative control with the sequence of AZD8233 sodium salt scrambled.
Bezeparsen sodium scrambled negative control V130114 Bezeparsen sodium scrambled negative control The Bezeparsen sodium scrambled negative control is a negative control for Bezeparsen sodium with a scrambled sequence.
BRD8518 V98901 BRD8518 1565828-01-4 BRD8518 is a PCSK9 inhibitor (EC50=0.23 μM).
Cepadacursen sodium V87646 Cepadacursen sodium 2252375-14-5 Cepadacursen sodium is a liver-targeted antisense oligonucleotide that inhibits proprotein convertase/subtilisin/kexin type 9 (PCSK9) protein synthesis.
Cepadacursen sodium scrambled negative control V131381 Cepadacursen sodium scrambled negative control The Cepadacursen sodium scrambled negative control is a negative control with the sequence of Cepadacursen sodium scrambled.
CVI-LM001 V87648 CVI-LM001 CVI-LM001 is a PCSK9 inhibitor that regulates the level of low-density lipoprotein cholesterol (LDL-C) in the blood by inhibiting the interaction between PCSK9 and low-density lipoprotein receptor (LDLR), thereby exerting a lipid-lowering effect.
DC371739 V87324 DC371739 2135765-21-6 DC371739 is a potent, orally active PCSK9 inhibitor.
E28362 V87654 E28362 930017-01-9 E28362 is a small molecule PCSK9 inhibitor.
Enlicitide (decanoate) V135106 Enlicitide (decanoate) 2861205-06-1 Enlicitide (decanoate) is an orally effective cyclic peptide PCSK9 inhibitor.
MeIm V99540 MeIm 2043947-71-1 MeIm (compound 7) is a high-affinity PCSK9-targeting peptide mimetic with cholesterol-lowering activity.
PCSK9 allosteric binder-1 V99859 PCSK9 allosteric binder-1 2215932-06-0 PCSK9 Allosteric Binder-1 (Example 70) is a PCSK9 allosteric binder.
PCSK9 autophagic degrader 2 V142309 PCSK9 autophagic degrader 2 2974497-11-3 PCSK9 autophagic degrader 2 is a PCSK9-targeted autophagosome with a DC50 of 20.6 nM.
PCSK9 Inhibitor, EGF-A V142310 PCSK9 Inhibitor, EGF-A PCSK9 Inhibitor, EGF-A is a PCSK9 inhibitor.
PCSK9-IN-26 V87649 PCSK9-IN-26 3033361-09-7 PCSK9-IN-26 (Compound 116) is a PCSK9 inhibitor (IC50 < 1 nM).
PCSK9-IN-27 V87651 PCSK9-IN-27 PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM).
Contact Us